Primary Record
Lactosylceramide
- In stock
- 9,167 g
- Purity
- 99.4 %
- CAS
- 125712-73-4
Compound Identifiers & Properties
- CAS
- 125712-73-4
- PubChem CID
- 10260120
- SMILES
- CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCC
Names & Synonyms
- Lactosylceramide
- LacCer
- Cytolipin H
- CDw17 antigen
- A1CDL
- lactosyl-n-acylsphingosine
- LacCer(d18:1/18:0)
- RefChem:1088320
- N-(octadecanoyl)-1-b-lactosyl-sphing-4-enine
- Lactosylceramide (porcine RBC)
- SCHEMBL29358702
- CHEBI:84759
- N-Lignoceryl sphingosyl lactoside
- C48H91NO13
- DTXSID301343901
- Gal-beta1->4Glc-beta1->1'Cer
- AFA71273
- Lactosylceramide (d18:1/18:0)
- HY-N10636
- Lactosyl ceramide (d18:1/18:0)
- 125712-73-4
- CID10260120
- D-Galactosyl-1,4-beta-D-glucosylceramide
- DA-72817
- CS-0621063
- J1.643.517A
- J2.963.443B
- beta-D-Galactosyl-1,4-beta-D-glucosylceramide
- C18 Lactosyl(?) Ceramide (d18:1/18:0)
- C18 Lactosyl(|A) Ceramide (d18:1/18:0)
- C18 Lactosyl(beta) Ceramide (d18:1/18:0)
- delta-Galactosyl-1,4-beta-delta-glucosylceramide
- N-(octadecanoyl)-1-beta-lactosyl-sphing-4-enine
- beta-delta-Galactosyl-1,4-beta-delta-glucosramide
- Lactosylceramide; LacCer; (Gal)1 (Glc)1 (Cer)1
- Beta-delta-Galactosyl-1,4-beta-delta-Glucosylceramide
- Q27158045
- D-lactosyl-beta-1,1' N-stearoyl-D-erythro-sphingosine
- D-lactosyl-I(2)-1,1a?N-stearoyl-D-erythro-sphingosine
- 1-O-(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)-Ceramide
- 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide
- beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-octadecanoylsphingosine
- D-lactosyl-|A-1,1 inverted exclamation marka N-stearoyl-D-erythro-sphingosine
- N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]octadecanamide
- 1-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-delta-galactopyranosyl-beta-delta-glucopyranosyl)-Ceramide
- 1ylce-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-D-Galactopyranosyl-beta-D-glucopyranosyl)-N-octadecanoylsphingosine
- 1-O-[4-O-(beta-D-Galactopyranosyl)-beta-D-glucopyranosyl]-N-stearoylsphingosine
- N-Octadecanoyl-1-O-(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)sphingosine
- CDH
- N-[(1S,2R)-1-[[4-O-(beta-D-Galactopyranosyl)-beta-D-glucopyranosyloxy]methyl]-2-hydroxy-3-heptadecene-1-yl]octadecaneamide
- N-[(2S,3R)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadecanamide
- N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadecanamide
- N-[(2S,3R,4E)-1-{[4-O-(beta-D-galactopyranosyl)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadecanamide
- N-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]octadecanamide
- Octadecanamide,N-[(1S,2R,3E)-1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecenyl]-